Registration is open for our next REVIVE webinar! 🤗 We'll discuss "Susceptibility testing in #antibacterial drug R&D" with Dee Shortridge JMI Laboratories and Rafael Canton Microbiología Clínica RyC 🧫🔬🦠 Make sure to join! 👇👇 Register now: attendee.gotowebinar.com/register/19567…

Incredibly informative report from the team at JMI Laboratories on longitudinal (2016-2020) resistance patterns in E. coli and K. pneumo. Lots of pertinent info but a few things that stood out: Link: academic.oup.com/ofid/article/1…

📅 2 March 2023 That's the date of our next REVIVE webinar! 🤩 Together with Dee Shortridge JMI Laboratories and Rafael Canton Microbiología Clínica RyC 🧫🔬🦠 we will discuss susceptibility testing in antibacterial drug R&D. Register now: attendee.gotowebinar.com/register/19567…

We're happy to share the completion of our 2022 SENTRY Antimicrobial Surveillance Testing!

Just discovered the JMI Laboratories SENTRY database’s public-facing page (late to the party, I know). This is SO COOL for looking at resistance rates/patterns! Can also do granular queries for specific genes/phenotypes/bugs/etc. sentry-mvp.jmilabs.com

Fellows in-training, residents and medical students are invited to present cases at #IDWeek2023. Selected cases will be featured in Fellows’ Day workshops, and travel grants up to $800 are available to cover expenses. Submit your case by May 3: idweek.org/presenters/

Over 800 registrations! 🤩 Many thanks to all the participants for this amazing webinar. Recording now available 👇 revive.gardp.org/susceptibility… JMI Laboratories Rafael Cantón Microbiología Clínica RyC 🧫🔬🦠 #antibacterialdrug #webinar

Congratulations to Mundipharma on their FDA approval for rezafungin (rezzayo)! fda.gov/drugs/new-drug…

Drug-resistant fungal infections increased according to Scientific American: scientificamerican.com/article/cases-…

.AMA Manual of Style, do you have an official designation for which countries fall into Eastern vs. Western Europe? And, if so, how was this divided? By WHO regulations or something else?

Have you reviewed the late 2022 World Health Organization (WHO)'s fungal priority pathogens list? who.int/publications/i…

In Q1 2023, we published 12 peer-review articles. Read them here: jmilabs.com/?pub_filter_ty…

“Aztreonam/avibactam activity was not adversely affected by clinically relevant CPEs. Our results support aztreonam/avibactam development to treat infections caused by CRE, including MBL producers” doi.org/10.1093/jacamr… JMI Laboratories Helio Sader #JACAMRNews

The process of naming bacteria follows specific rules – but do you know what they are? Fun Friday read from ID Transmission ow.ly/hxns50NmFoP #infectiousdiseases #pathology #microbiology #scicomms #IDTwitter

We're looking forward to seeing you soon at #ECCMID2023!

Interesting!

🤝 We are entering into a 6-year collaboration with JMI Laboratories to undertake to evaluate the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against #AMR. Read more: biomerieux.com/corp/en/who-we… Element Materials Technology

Congratulations to our team at JMI Laboratories who are partnering with bioMérieux to fight #antimicrobial resistance. 🦠 Read more here: element.com/about-element/…

#ECCMID2023 might have ended, but you can still access our posters on our website: jmilabs.com/?pub_filter_ty…

"The potent in vitro activity of sulopenem against this large collection of recent Enterobacterales and anaerobic clinical isolates from various infection types support its further clinical evaluation to treat IAIs and UTIs" doi.org/10.1093/jac/dk… JMI Laboratories #OpenAccess #JACNews